Early (4th Week) Versus Late (6thweek) Interval Postpartum Copper Intrauterine Device Insertion: a Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Assiut University
- Locations
- 1
- Primary Endpoint
- The number of participants use the device
Study Overview
Brief Summary
The optimal interval between pregnancies is debated, but a duration greater than 11-18 months has been suggested as reducing complications in the subsequent pregnancy. Improved birth spacing can be a key benefit use of long-acting reversible contraception, but delay to initiation can still be problematic.So women who have recently given birth can be cost-effectively targeted for family planning education and engagement because often they are already connected with health professionals
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Health Services Research
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 40 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Delivered (vaginal or Cesarean) a singleton living baby ≥28weeks gestation. Women desire birth spacing for one year or more. Women who will accept to participate in the study and follow up.
Exclusion Criteria
- •Known uterine anomalies.
- •Women with previous ectopic pregnancy.
- •Presence of postpartum pyrexia.
- •Women with history of postpartum hemorrhage in the last delivery either primary or secondary.
- •Retained products of conception.
- •History of previous uterine perforation.
- •Anticipation of difficulty of subsequent follow-up with the women.
- •Women with uncontrolled diabetes and hypertension.
- •Women who wish to use other contraceptive methods.
Arms & Interventions
insertion by the end of the 4th week postpartum
Intervention: early insertion (Procedure)
insertion by the end of the 6th week postpartum
Intervention: late insertion (Procedure)
Outcomes
Primary Outcomes
The number of participants use the device
Time Frame: 6 weeks
number of women place the intrauterine device within 6 weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Ahmed Mohamed Abbas
Clinical Professor
Assiut University